MOMark Onslow

Mark Onslow

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Mark Onslow has a total of 27 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Camperdown Program for adults who stutter: a student training clinic Phase I trial

    by Nadia Cocomazzo, Susan Block, Brenda Carey, Sue O’bRian, Mark Onslow, Ann Packman, Lisa Iverach

    : Objectives: During speech pathology professional preparation there is a need for adequate student instruction with speech‐restructuring treatments for adults. An important part of that clinical educational experience is to participate in a clinical setting that produces outcomes equivalent to those attained during clinical trials. A previous report showed that this is possible with a traditional, intensive speech‐restructuring treatment. Considering the treatment process advantages and time efficiency of the Camperdown Program, it is arguably a compelling prospect for clinician education. Therefore, the present study is a Phase I trial of the treatment at a student university clinic, with a similar design to a previous report.Background: During speech pathology professional preparation there is a need for adequate student instruction with speech‐restructuring treatments for adults. An important part of that clinical educational experience is to participate in a clinical setting that produces outcomes equivalent to those attained during clinical trials. A previous report showed that this is possible with a traditional, intensive speech‐restructuring treatment. Considering the treatment process advantages and time efficiency of the Camperdown Program, it is arguably a compelling prospect for clinician education.Aims: The present study is a Phase I trial of the treatment at a student university clinic, with a similar design to a previous report.Methods & Procedures: The design was a non‐randomized Phase I clinical trial with 12 adult participants. Primary outcomes were per cent syllables stuttered (%SS) within and beyond the clinic, and speech naturalness scores from pre‐ and post‐treatment stutter‐free speech samples.Outcomes & Results: Pooled %SS scores pre‐treatment were 5.7, at immediate post‐treatment were 1.0, and at 12 months post‐treatment were 2.4. The group speech naturalness scores post‐treatment did not increase to a clinically significant extent.Conclusion & Implications: Results essentially replicate the previous study by producing similar outcomes to those attained with clinical trials. The Camperdown Program is recommended as a clinical environment for speech‐restructuring speech pathology student training.


  • Dual tasking and stuttering: from the laboratory to the clinic

    by Christine Metten, Hans-Georg Bosshardt, Mark Jones, John Eisenhuth, Susan Block, Brenda Carey, Sue O'BRian, Ann Packman, Mark Onslow, Ross Menzies

    Purpose. The aim of the three studies in this article was to develop a way to include dual tasking in speech restructuring treatment for persons who stutter (PWS). It is thought that this may help clients maintain the benefits of treatment in the real world, where attentional resources are frequently diverted away from controlling fluency by the demands of other tasks. Method. In Part 1, 17 PWS performed a story-telling task and a computer semantic task simultaneously. Part 2 reports the incorporation of the Part 1 protocol into a handy device for use in a clinical setting (the Dual Task and Stuttering Device, DAS-D). Part 3 is a proof of concept study in which three PWS reported on their experiences of using the device during treatment. Results. In Part 1, stuttering frequency and errors on the computer task both increased under dual task conditions, indicating that the protocol would be appropriate for use in a clinical setting. All three participants in Part 3 reported positively on their experiences using the DAS-D. Conclusions. Dual tasking during treatment using the DAS-D appears to be a viable clinical procedure. Further research is required to establish effectiveness.


  • Mood and Substance Use Disorders Among Adults Seeking Speech Treatment for Stuttering

    by Lisa Iverach, Mark Jones, Sue O’bRian, Susan Block, Michelle Lincoln, Elisabeth Harrison, Sally Hewat, Ross G. Menzies, Ann Packman, Mark Onslow

    Objectives: Stuttering has been associated with a range of anxiety disorders, including social phobia. In the general community, anxiety disorders are frequently associated with increased rates of mood and substance use disorders. Therefore, in the present study, the authors sought to determine the rate of mood and substance use disorders among adults who stutter. Method: The study employed a matched case–control design. Participants included 92 adults seeking treatment for stuttering and 920 age- and gender-matched controls. Mental health assessments were conducted via a computerized psychiatric diagnostic interview. Conditional logistic regression models were used to estimate odds ratios for the prevalence of mood and substance use disorders in both groups. Results: When compared with matched controls, adults seeking treatment for stuttering had twofold increased odds of meeting criteria for a 12-month diagnosis of any mood disorder but were not found to report significantly higher lifetime prevalence rates for any substance use disorder. Conclusions: Although adults who stutter in the present study were characterized by significantly higher rates of mood disorders than matched controls, they do not appear to self-medicate with substances such as alcohol. Results are discussed in terms of treatment implications and possible reasons why adults who stutter may avoid alcohol.


  • Randomized controlled non‐inferiority trial of a telehealth treatment for chronic stuttering: the Camperdown Program

    by Brenda Carey, Sue O'BRian, Mark Onslow, Susan Block, Mark Jones, Ann Packman

    Background: Although there are treatments that can alleviate stuttering in adults for clinically significant periods, in Australia there are barriers to the accessibility and availability of best‐practice treatment.Aims: This parallel group, non‐inferiority randomized controlled trial with multiple blinded outcome assessments investigated whether telehealth delivery of the Camperdown Program provides a non‐inferior alternative to face‐to‐face treatment for adults who stutter.Methods & Procedures: Forty participants who presented to a university speech clinic were randomized: 20 to the telehealth arm and 20 to the face‐to‐face arm. Exclusion criteria were age younger than 18 years, frequency of stuttering less than 2% of syllables stuttered and previous speech‐restructuring treatment within the past 12 months. The Camperdown Program for adults who stutter was the intervention. Primary outcome measures were frequency of stuttering measured in per cent syllables stuttered (%SS) before treatment and at 9 months post‐randomization and efficiency, measured by counting the number of speech pathologist contact hours used by each participant. Intention to treat analysis was conducted using last observation carried forward. Secondary outcome measures were speech naturalness, self‐reported stuttering severity, and treatment satisfaction.Outcomes & Results: There was no statistically or clinically significant difference in %SS between the two groups at 9 months post‐randomization. Analysis of covariance adjusting for baseline %SS showed telehealth had 0.8% absolute lower per cent syllables stuttered than face‐to‐face. There were also no differences in %SS between groups immediately post‐treatment, or at 6 months and 12 months post‐treatment (p = 0.9). In the second primary outcome measure, the telehealth group used statistically less contact time (221 min) on average than the face‐to‐face group (95% confidence interval = − 387 to − 56 min, p = 0.01).Conclusions & Implications: The results provide evidence to support the use of the Camperdown Program delivered by telehealth as an alternate to the face‐to‐face treatment delivery of this programme for adults who stutter. Such a model will increase accessibility to this evidence‐based treatment for adults currently isolated from treatment services.Trial registration: Current Controlled Trials ISRCTN 48954432.


  • Self‐modelling as a relapse intervention following speech‐restructuring treatment for stuttering

    by Angela Cream, Sue O'Brian, Mark Onslow, Ann Packman, Ross Menzies

    Background: Speech restructuring is an efficacious method for the alleviation of stuttered speech. However, post‐treatment relapse is common.Aims: To investigate whether the use of video self‐modelling using restructured stutter‐free speech reduces stuttering in adults who had learnt a speech‐restructuring technique and subsequently relapsed.Methods & Procedures: Participants were twelve adults who had previously had speech‐restructuring treatment for stuttering and relapsed. They were video recorded for 1 hour within the clinic, practising their speech‐restructuring technique. The videos were then edited to remove all observable stuttering. Participants then viewed the resulting video of themselves using restructured stutter‐free speech each day for 1 month and were instructed to speak as they did on the video. Beyond‐clinic speech samples and self‐report severity data were collected before and after the intervention.Outcomes & Results: Very large effect sizes were found. The mean per cent syllables stuttered was 7.7 pre‐intervention and 2.3 post‐intervention. For all but one participant there was a reduction in stuttering from pre‐intervention to post‐intervention. These results were verified with self‐report data. Speech naturalness was not compromised by the video self‐modelling procedure.Conclusion & Implications: Video self‐modelling as a relapse management tool does not involve excessive time expenditure by the clinician or the client. The study indicates video self‐modelling is potentially useful for managing relapse after speech‐restructuring treatment for stuttering, and in some cases may be a stand‐alone procedure to manage relapse. Phase II and III trials are warranted to determine the size and duration of the effect. It is suggested video self‐modelling could also be included in a relapse management plan.


  • Unhelpful thoughts and beliefs linked to social anxiety in stuttering: development of a measure

    by Tamsen St Clare, Ross G. Menzies, Mark Onslow, Ann Packman, Robyn Thompson, Susan Block

    Background: Those who stutter have a proclivity to social anxiety. Yet, to date, there is no comprehensive measure of thoughts and beliefs about stuttering that represent the cognitions associated with that anxiety.Aims: The present paper describes the development of a measure to assess unhelpful thoughts and beliefs about stuttering.Methods & Procedures: The Unhelpful Thoughts and Beliefs about Stuttering (UTBAS) self‐report measure contains 66 items that assess the frequency of unhelpful thoughts and beliefs. Items were constructed from a comprehensive file audit of all stuttering cases seen in a cognitive–behavior therapy based treatment programme over a ten‐year period.Outcomes & Results: Preliminary investigations indicate that the UTBAS has high levels of test–retest reliability (r = 0.89) and internal consistency (Chronbach's alpha = 0.98). It has good known‐groups validity, being able to discriminate between stuttering and non‐stuttering participants on items that contain no reference to stuttering [t(38) = 8.06, pd = 2.3). It has good convergent validity (r = 0.53–0.72) and discriminant validity (r = 0.24–0.27). The UTBAS sensitivity to change was supported by improvements in thoughts and beliefs related to social anxiety following cognitive–behavioural treatment for anxiety in stuttering [t(25) = 10.13, pd = 2.5).Conclusions & Implications: Implications for the use of the UTBAS as an outcome measure and a clinical tool are discussed, along with the potential value of the UTBAS to explore the well‐documented social anxiety experienced by those who stutter.


  • An Experimental Clinical Trial of a Cognitive-Behavior Therapy Package for Chronic Stuttering

    by Ross G. Menzies, Sue O’bRian, Mark Onslow, Ann Packman, Tamsen St Clare, Susan Block

    Purpose: The aims of the present study were to (a) examine the rate of social phobia among adults who stutter, (b) study the effects of speech restructuring treatment on social anxiety, and (c) study the effects on anxiety and stuttering of a cognitive-behavior therapy (CBT) package for social anxiety. Method: Thirty-two adults with chronic stuttering were randomly allocated to receive either speech restructuring following a CBT package for social anxiety or speech restructuring alone. Data were obtained on a variety of speech and psychological measures at pre-treatment, post-CBT, post–speech restructuring, and 12 months follow-up. Results: Sixty percent of our cohort were diagnosed with social phobia. Speech restructuring treatment alone had no impact on the social phobia of our cohort at 12 months follow-up. At follow-up, participants who had received CBT showed no social phobia and greater improvements than control participants on a range of psychological measures of anxiety and avoidance. However, the CBT package made no difference to the speech outcomes of those with social phobia. Conclusion: The CBT treatment was associated with significant and sustained improvements in psychological functioning but did not improve fluency.


  • Extended follow‐up of a randomized controlled trial of the Lidcombe Program of Early Stuttering Intervention

    by Mark Jones, Mark Onslow, Ann Packman, Sue O'BRian, Anna Hearne, Shelley Williams, Tika Ormond, Ilsa Schwarz

    Background: In the Lidcombe Program of Early Stuttering Intervention, parents present verbal contingencies for stutter‐free and stuttered speech in everyday situations. A previous randomized controlled trial of the programme with preschool‐age children from 2005, conducted in two public speech clinics in New Zealand, showed that the odds of attaining clinically minimal levels of stuttering 9 months after randomization were more than seven times greater for the treatment group than for the control group.Aims: To follow up the children in the trial to determine extended long‐term outcomes of the programme.Methods & Procedures: An experienced speech–language therapist who was not involved in the original trial talked with the children on the telephone, audio recording the conversations using a telephone recording jack. Parental reports were gathered in addition to the children's speech samples in order to obtain a balance of objective data and reports from a wide range of situations.Outcomes & Results: At the time of this follow‐up, the children were aged 7–12 years, with a mean of 5 years post‐randomization in the 2005 trial. Twenty of the 29 children in the treatment arm and eight of the 25 children in the control (no treatment) arm were able to be contacted. Of the children in the treatment group, one (5%) failed to complete treatment and 19 had completed treatment successfully and had zero or near‐zero frequency of stuttering. Three of the children (16%) who had completed treatment successfully had relapsed after 2 or more years of speech that was below 1% syllables stuttered. Meaningful comparison with the control group was not possible because an insufficient number of control children were located and some of them received treatment after completing the trial.Conclusions & Implications: The majority of preschool children are able to complete the Lidcombe Program successfully and remain below 1% syllables stuttered for a number of years. However, a minority of children do relapse and will require their parents to reinstate the treatment procedures.


  • Defining, Identifying, and Evaluating Clinical Trials of Stuttering Treatments: A Tutorial for Clinicians

    by Mark Onslow, Mark Jones, Sue O’bRian, Ross Menzies, Ann Packman

    Purpose: To develop a method for clinicians to evaluate stuttering treatment efficacy research with very little burden of work. Method: The clinical trial is the most fundamental, clinically interpretable, and useful output unit of stuttering treatment research. We define a clinical trial of a stuttering treatment and specify 3 levels of clinical trials evidence. We use this taxonomy to identify and evaluate clinical trials of stuttering treatment. Our taxonomy draws on 2 fundamental principles of clinical trials used to evaluate health care: randomization and effect size. Results: Published clinical trials of stuttering treatments were identified and allocated to 1 of 3 levels of evidence. Conclusions: We outline a 3-step, semi-automated, Internet-based method to identify the publication of a report of stuttering treatment efficacy. For a report identified as such, a 10-item checklist is applied to verify its status as a clinical trial and to allocate it to 1 of 3 levels of clinical trials evidence. The present taxonomy reduces the burden of work of a 136-item checklist in an existing taxonomy.


  • Developing Treatment for Adolescents Who Stutter: A Phase I Trial of the Camperdown Program

    by Anna Hearne, Ann Packman, Mark Onslow, Sue O’bRian

    Purpose: To investigate in detail how adolescents who stutter perform during treatment, with the aim of informing treatment development for this age group. Method: The Camperdown Program was conducted with 3 adolescents who stutter. Their performance during treatment was recorded in detail, and outcome measures were collected before treatment and on 5 occasions after treatment. Results: One participant responded extremely well to treatment, with percentage of syllables stuttered (%SS) scores at 12 months follow-up around 1%. In addition, his speech naturalness was within normal limits. Another participant withdrew from treatment during maintenance, yet he still approximately halved his pretreatment %SS scores and was also sounding natural after treatment. This participant was satisfied with his treatment outcome. A third participant did not reach maintenance and did not benefit from the treatment. Conclusion: The adolescent who succeeded in treatment presented with a high level of self-confidence and maturity. When examining the factors that seemed to impact on treatment outcome, an underlying theme of decreased parent influence and increased peer influence and self-direction was detected. These are fundamental during the journey through adolescence from childhood to adulthood. Future directions in developing treatments for adolescents are discussed.